Oncologist and Professor- Mikhail Blagosklonny

Science is his passion, and he has been studying and practicing it to assist others. Mikhail Blagosklonny is a scientist by profession and he as specialized on cancer and aging. Mr. Mikhail can well be described a professor of oncology. Professor Blagosklonny is a professor of oncology at the Roswell Park Cancer Institute in New York.

According to his LinkedIn profile, Mikhail Blagosklonny loves science and aft6er his high school graduation he proceeded to study at the First Pavlov State Medical University of St. Peterburg, where he earned his M.D in internal medicine and Ph.D. in Cardiology. Since his early age, Mikhail has been portraying positive leadership skills a character that led him to be appointed as an associate professor of medicine at New York Medical College in 2002. He also took another leadership position as a senior scientist at Ordway Research Institute. Professor Blagosklonny held the position until 2009 when he was appointed to be the professor of oncology at Roswell Park Cancer Institute.

Mikhail Blagosklonny, majors his studies and research on aging and cancer treatment. His research target cancer therapies that secure healthy cells from damages well as assisting in the ant-aging mechanism. In his research as well as studies, Mikhail has come up with a formula for preventing aging; he advises on using rapamycin which a popular cancer drug. Mikhail is sure that the drug will help to prolong life. Mikhail is considered to one of the most passionate scientists and an advocate of rapamycin in the treatment and prevention of aging.

Dr. Blagosklonny became a senior professor at the Roswell Park Cancer Institute in 2009. Mikhail was appointed due to his great contribution and experience that he gained from working with other educational institutions as well as research institutes in the United States. Dr. Mikhail; has also established several organizations including Oncotarget. Oncotarget is a medical journal which covers on aging and oncology. He co-founded Oncotarget in 2010 together with Andrei Gudkov. In addition to his medical studies and research, Dr. Mikhail also edits medical journals including Cancer Biology and Therapy. Mikhail Blagosklonny serves on the editorial board of Cell Death and Differentiation. Mikhail is an author and has authored more than 270 papers and 250000 citations

Leave a Reply

Your email address will not be published. Required fields are marked *